Stocks to Watch: Seer, Orthofix Medical, Halozyme Therapeutics

Dow Jones
07/03
 
 

Seer Chief Executive Officer and Chair Omid Farokhzad offered to buy the company for $2.45 a share in cash, plus two contingent value rights. Shares surged 39%, to $2.25, after the bell on Thursday.

Orthofix Medical said Medicare reimbursement rates are being restored to original levels following a reversal from the Centers for Medicare & Medicaid Services. The stock gained 7.9%, to $10.72, in after-hours trading.

Halozyme Therapeutics said its chief operating officer was leaving the company. Shares fell 3.1%, to $77.00.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

July 02, 2026 18:57 ET (22:57 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10